Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.5	47.92	65.06	90.03	139.07
Short-Term Investments	156.49	174.37	281.34	408.17	214
Cash & Short-Term Investments	226.98	222.29	346.4	498.2	353.06
Cash Growth	2.11%	-35.83%	-30.47%	41.11%	-48.70%
Accounts Receivable	50.37	41.73	37.97	40.06	17.41
Other Receivables	-	1.3	1	0.8	1.4
Receivables	50.37	43.03	38.97	40.86	18.81
Inventory	9.82	8.44	14.45	14.45	19.26
Prepaid Expenses	13.02	9.99	10.37	8.64	11.62
Total Current Assets	300.19	283.75	410.19	562.15	402.75
Property, Plant & Equipment	74.72	94.38	120.32	164.21	172.94
Long-Term Investments	13.23	33.66	-	-	217.15
Goodwill	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	1.73	3.43	5.13	6.83	8.53
Other Long-Term Assets	3.9	5.18	6.52	4.46	3.01
Total Assets	512.74	539.38	661.13	856.62	923.34
Accounts Payable	6.47	7.27	7.72	8.08	3.31
Accrued Expenses	24.69	20.67	20.39	24.1	22.2
Current Portion of Long-Term Debt	4.64	0.87	-	-	-
Current Portion of Leases	8.92	10.24	9.38	9.23	5.06
Current Income Taxes Payable	-	0.18	0.06	0.19	0.39
Current Unearned Revenue	45.19	55.69	48.63	64.12	80.46
Other Current Liabilities	-	3.15	1.84	4.07	2.39
Total Current Liabilities	89.92	98.05	88.02	109.79	113.81
Long-Term Debt	126.57	132.41	130.66	125.36	-
Long-Term Leases	70.23	79.15	89.39	98.77	106.69
Long-Term Unearned Revenue	1.01	27.26	44.79	58.6	98.75
Other Long-Term Liabilities	0.02	0.02	-	-	-
Total Liabilities	287.74	336.89	352.86	392.52	319.24
Common Stock	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,582	1,506	1,453	1,387	1,324
Retained Earnings	-1,363	-1,304	-1,144	-919.08	-718.89
Comprehensive Income & Other	0.25	0.17	0.22	-4.12	-1.14
Total Common Equity	218.79	202.71	308.4	464.17	603.99
Minority Interest	6.21	-0.22	-0.12	-0.07	0.11
Shareholders' Equity	225	202.49	308.28	464.1	604.1
Total Liabilities & Equity	512.74	539.38	661.13	856.62	923.34
Total Debt	210.36	222.67	229.43	233.36	111.74
Net Cash (Debt)	29.86	33.29	116.97	264.83	458.47
Net Cash Growth	-10.30%	-71.54%	-55.83%	-42.23%	-34.41%
Net Cash Per Share	0.20	0.23	0.81	1.86	3.27
Filing Date Shares Outstanding	153.78	148.58	145.09	143.23	141.58
Total Common Shares Outstanding	153.78	147.77	145.08	143.11	141.39
Working Capital	210.27	185.7	322.17	452.36	288.94
Book Value Per Share	1.42	1.37	2.13	3.24	4.27
Tangible Book Value	98.1	80.31	184.3	338.37	476.49
Tangible Book Value Per Share	0.64	0.54	1.27	2.36	3.37
Machinery	-	59.33	61.36	56.7	48.88
Construction In Progress	-	2.57	3.41	7.63	5.66
Leasehold Improvements	-	73.28	74.73	72.4	65.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.